A very nice article from China that confirms basic mechanism of #murcidencel #DCVax $NWBO

Al Musella wrote that in one case, $NWBO’s “DCVax targeted over 11,000 targets, a remarkable finding considering that many other vaccines currently in trials target only one to six targets.”

Let's be clear. This slide deck, while interesting and timely, was not peer-reviewed and did not qualify, under ASCO standards, as true scientific research. It was more a sophisticated form of advertising, marketing, and promotion for the company that makes #DCVax.

Here's a question for $NWBO followers in the Twitterverse: If #DCVax-L #murcidencel is approved in the UK, then, for a Medicare patient in the USA with glioblastoma, will Medicare pick up the cost of the surgery - and will the patient need to bear the cost of #DCVax?

$NWBO

Must read for every $NWBO shareholder.

Dr Bosch clearly pointed out that #DCVax is tumor agnostic. So what is tumor agnostic? See the image below. Most of don't really know the true value of this stock. $NWBO

Agree but hey let's give a little credit to Jerry Jasinowski, $NWBO board member and former president of the The NAM National Association of Manufacturers and visionary behind the first Dream it Do it! campaign.

Agree! $NWBO #murcidencel no time to waste . . .and don't forget the AIVITA Biomedical Inc. dendritic cell vaccine product

Agree! Perhaps this news story will light a fire under some derrieres at 4800 Montgomery Lane in Bethesda, Maryland. $NWBO #murcidencel

I like this graph. $NWBO #murcidencel

Interesting story, thanks for sharing. $NWBO #murcidencel

uclahealth.org/news/fda-appro… $NWBO #murcidencel #dcvax Note this language: the therapy awaits submission for approval to the FDA. Therefore, we still have a long time to wait.

This week we honor the brave patients who are fighting valiantly against #glioblastoma. Dr. Donald O'Rourke and I want you to hear the story of Rachel Rabinowitz, robbed of a promising life by the beast, and whose mother Kathy Savitz has been an amazing advocate for research.

Excellent plenary lecture from Prof Keyoumars Ashkan King's Neurosurgery Dendritic cell immunotherapy for Glioblastoma #SBNSLONDON2023

#dcvax #allsolidtumors $nwbo #gbm investorshub.advfn.com/boards/read_ms…

#dcvax #allsolidtumors $nwbo #gbm King's College Hospital Research @KCH_Research · Oct 30 For #InternationalBrainTumourAwarenessWeek, we hear from Professor Keyoumars Ashkan, Lead Clinician for Neuro-Oncology about ongoing research studies that can help with brain tumour

#dcvax #allsolidtumors $nwbo #gbm Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma Front. Neurol., 31 October 2023 "Recently, in 2023, Liau et al. revealed the results from a large Phase

Agree with this analysis. There may have been a misprint/proofreading error in the October 13 press release, in which the word "November" was mistakenly used instead of "December."

This is not good news for people who hold shares of $NWBO.